DORRANCE LAB

We are focused on understanding the underlying mechanisms involving the process of leukemogenesis to identify novel targeted therapies.

 

Acute Myeloid Leukemia (AML) is a disease that occurs in children and adults. Although several new FDA therapies have been approved in recent years the overall survival for patients with this disease is dismal. We can do better.

Photography provided by Jared Chambers